BROAD OAK MEDICAL PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: Y06792 | NOTTINGHAM, NG8 6LN
Showing results 151-200 of 464
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Azithromycin | 138 | 3,889 | £957 | +8.9% ▲ |
| Clarithromycin | 136 | 2,967 | £651 | -44.6% ▼ |
| Ferrous sulfate | 136 | 5,488 | £189 | -73.6% ▼ |
| Insulin glargine | 135 | 785 | £5.6K | -52.5% ▼ |
| Sacubitril/valsartan | 130 | 7,966 | £13.0K | -45.7% ▼ |
| 130 | 14.9K | £609 | -0.8% vs avg | |
| 130 | 61.2K | £716 | +42.6% ▲ | |
| Biphasic insulin aspart | 129 | 926 | £5.5K | +27.0% ▲ |
| Prochlorperazine maleate | 128 | 5,847 | £309 | -36.7% ▼ |
| Edoxaban | 127 | 4,144 | £6.9K | -81.9% ▼ |
| Clotrimazole | 127 | 1,255 | £1.1K | +15.1% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 127 | 869.0K | £17.5K | +81.5% ▲ |
| Combined ethinylestradiol 30mcg | 126 | 11.7K | £370 | -54.6% ▼ |
| Dexamethasone | 125 | 640 | £399 | -27.3% ▼ |
| Beclometasone dipropionate | 125 | 125 | £375 | -41.9% ▼ |
| Mometasone furoate | 125 | 6,280 | £697 | -6.5% ▼ |
| Pizotifen malate | 122 | 6,846 | £302 | +48.0% ▲ |
| Calcipotriol | 121 | 7,980 | £4.6K | -28.9% ▼ |
| Famotidine | 118 | 4,725 | £2.5K | -75.8% ▼ |
| Umeclidinium bromide/vilanterol | 118 | 120 | £3.7K | -39.5% ▼ |
| Finasteride | 118 | 3,745 | £132 | -82.0% ▼ |
| Vitamin B compound | 114 | 7,735 | £313 | -18.2% ▼ |
| Insulin degludec | 113 | 651 | £6.1K | +2.8% ▲ |
| Ranolazine | 106 | 6,652 | £1.2K | -37.6% ▼ |
| Pantoprazole | 105 | 3,500 | £161 | -61.8% ▼ |
| Mesalazine (Systemic) | 103 | 4,076 | £3.2K | -57.0% ▼ |
| Powder extensively hydrolysed formula (0913101) | 103 | 271.6K | £8.5K | +43.0% ▲ |
| Mometasone furoate | 103 | 105 | £810 | -74.3% ▼ |
| Irbesartan | 102 | 3,605 | £165 | -58.1% ▼ |
| Estradiol | 102 | 2,320 | £1.3K | -62.2% ▼ |
| Anastrozole | 101 | 2,364 | £92 | +10.9% ▲ |
| Ropinirole hydrochloride | 100 | 4,179 | £2.2K | -5.9% ▼ |
| Clobazam | 95 | 2,289 | £259 | +44.1% ▲ |
| Ketone blood testing reagents | 95 | 1,500 | £2.4K | +40.4% ▲ |
| Nifedipine | 94 | 6,240 | £2.2K | -49.8% ▼ |
| Lymecycline | 94 | 3,780 | £434 | -21.9% ▼ |
| Sulfasalazine | 93 | 11.6K | £1.9K | -28.5% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 93 | 9,966 | £639 | -58.8% ▼ |
| Betahistine hydrochloride | 92 | 7,700 | £264 | -61.5% ▼ |
| Biphasic insulin lispro | 91 | 1,179 | £7.3K | +112.0% ▲ |
| Nystatin | 90 | 2,730 | £157 | -10.7% ▼ |
| Umeclidinium bromide | 89 | 89 | £2.3K | +44.4% ▲ |
| Chlorphenamine maleate | 89 | 11.7K | £384 | -19.4% ▼ |
| Flupentixol hydrochloride | 89 | 3,038 | £412 | +305.8% ▲ |
| Memantine hydrochloride | 89 | 2,677 | £503 | -73.1% ▼ |
| Metronidazole | 88 | 966 | £56 | +33.9% ▲ |
| Trimethoprim | 86 | 2,798 | £133 | -57.9% ▼ |
| Quinine bisulfate | 86 | 2,408 | £439 | +121.5% ▲ |
| Ketoconazole | 86 | 11.3K | £1.8K | -12.4% ▼ |
| Amisulpride | 83 | 2,576 | £1.2K | +18.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.